OTC · CIK 0000895464
YBGJ Yubo International Biotech Ltd
Insider trading from SEC Form 4. Last filing Jul 25, 2025. Close $0.01 on Oct 9, 2026, +5% from the 52-week low and -66% from the high.
Yubo International Biotech Ltd (YBGJ) has 4 SEC Form 4 filings on file from 3 insiders, the latest filed on Jul 25, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at YBGJ. The newest: Boao Biotech Ltd (10% owner) sold $1.5M of stock on Jan 25, 2024, filed Jun 3, 2025, scored 42 (moderate).
YBGJ closed at $0.01 on Oct 9, 2026, 5% above its 52-week low and 66% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Yubo International Biotech Ltd, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Boao Biotech Ltd owner sell | $1.5M 5,040,140 shares | -20% | - | |
| 43Moderate | Yang Wang Chief Executive Officer sell | $240k 2,000,000 shares | -10% | - |
Transactions
Every row filed, 12 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | Jun Wang President | AGrant or award Class A Common Stockindirect: Controlling Person of Entity | +42,000,000 | $0.05 | $2.1M | 81,943,800 | Jul 25, 2025 |
| Jul 23, 2025 | Yang Wang Chief Executive Officer | AGrant or award Class A Common Stockindirect: Controlling Person of Entity | +8,600,000 | $0.05 | $430k | 25,811,400 | Jul 25, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -500,000 | $0.30 | $150k | 24,467,800 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -741,521 | $0.30 | $222k | 23,726,279 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -301,701 | $0.30 | $91k | 23,424,578 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -364,351 | $0.30 | $109k | 23,060,227 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -181,256 | $0.30 | $54k | 22,878,971 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -86,897 | $0.30 | $26k | 22,792,074 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -426,654 | $0.30 | $128k | 22,365,420 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -2,057,586 | $0.30 | $617k | 20,307,834 | Jun 3, 2025 |
| Jan 25, 2024 | Boao Biotech Ltd owner | SOpen-market sale Class A Common Stock | -380,174 | $0.30 | $114k | 19,927,660 | Jun 3, 2025 |
| Jul 15, 2024 | Yang Wang Chief Executive Officer | SOpen-market sale Class A Common Stockindirect: Controlling Person of Entity | -2,000,000 | $0.12 | $240k | 17,211,400 | Jun 2, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Boao Biotech Ltdowner
- Jun WangPresident
- Yang WangChief Executive Officer
Questions about YBGJ
Answered from the filings on this page, as of the latest one.
Are insiders buying YBGJ?
No. In the last 90 days no insider at Yubo International Biotech Ltd bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade YBGJ on the open market?
Boao Biotech Ltd (10% owner) sold $1.5M of YBGJ on Jan 25, 2024 and filed the Form 4 on Jun 3, 2025. InsiderTell scored 42 (moderate).
How many insiders file Form 4 at Yubo International Biotech Ltd?
3 people have filed a Form 4 at Yubo International Biotech Ltd, among them Boao Biotech Ltd (10% owner), Jun Wang (President), Yang Wang (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.